IPCA Labs(Weekly): Critical Confluence at 50/100-WMA SupportIPCA Laboratories is currently testing a significant structural inflection point on the weekly timeframe. Price action is hovering at the convergence of the 50-Week and 100-Week Moving Averages (1,420 - 1,450 range). The resolution of this test will dictate the primary trend for the medium term, presenting two distinct, actionable scenarios.
Technical Context:
The 50-WMA and 100-WMA historically act as heavy dynamic support during primary uptrends. The stock is currently compressing at this confluence, requiring a definitive weekly close to confirm directional bias.
Scenario A: Bullish Continuation (Support Defended)
If buyers successfully defend this moving average confluence, the primary uptrend remains intact, setting up a continuation trade.
Thesis: Support holds, initiating a new impulsive wave upward.
Trigger: A strong, bullish weekly close above the 50-WMA and 100-WMA confluence.
Targets: Retest of structural resistance at 1,624 (Point X), followed by the All-Time High at 1,755.
Invalidation (SL): A close slightly below the 100-WMA or the recent structural swing low.
Scenario B: Bearish WXY Correction (Support Fails)
A breakdown below this major support confluence signals structural weakness and opens the door for a deeper macro correction.
Thesis: Failure to hold the 50/100-WMA confluence initiates a WXY double combo correction.
Trigger: A decisive weekly close below both the 50-WMA and 100-WMA.
Targets: Initial downside target at 1,168 (Wave W low). A sustained break below this level exposes the 1.0 Fibonacci extension at 1,036, which aligns with the deeper 200-WMA.
Invalidation (SL): A close back above the 50-WMA.
Summary:
Directional bias is currently neutral pending a weekly close. Market participants should wait for candle confirmation to dictate entry and adhere strictly to defined invalidation levels to manage downside risk.
Disclaimer: Pleae DYOR. Not a buy/sell recommendation. Educational only.
IPCA Laboratories Limited
No trades
In-depth trading ideas
IPCA Labs cmp 1586 by Daily Chart viewIPCA Labs cmp 1586 by Daily Chart view
- Support Zone 1470 to 1530 Price Band
- Resistance Zone 1610 to 1675 Price Band then ATH
- Considerate VCP pattern too seems in likely formation
- Volumes in sync with and crossing beyond avg traded qty
- Rounding Bottoms formed around & by Support Zone neckline
- Breakout seems likely anticipated from Falling Resistance Price Channel
IPCALAB : Multiple time resistance hit; ready to flyIPCA LAB is near breakout; multiple time hit its resistance. now looking a very good position to enter.
All data is available in public domain..
CMP : 1557
TG : 1750
SL : 1450
R/R : times (Risk to Reward)
Stock's selection based on 5 Point Analysis:
1: Idea : near Breakout.
2: Support : Volume, Delivery .
3: Technical : 21/55/200-EMA, Super trend up, RS>0 RSI.
4: Fundamental : PE, PAT, Industry & peer PE and sector performance.
5: Timing : Entry Timing on Daily chart.
Disclaimer : It is my personal view as a trader and for educational purpose only. Equity market involves risk .
Please consult your financial adviser before taking any decision.
Disclosure : Holding
IPCA Lab (W): Bullish (Multi-Year Consolidation Breakout)(Timeframe: Weekly | Scale: Logarithmic)
IPCA Laboratories is emerging from a massive multi-year basing phase. The stock has successfully broken out of a macro consolidation pattern and is currently executing a healthy pullback/accumulation phase, positioning itself for a run toward its 52-week highs.
📈 1. The Chart Structure (The Base Breakout)
> The Squeeze: For much of the last year, the stock absorbed overhead supply in a large "Pennant" or "Falling Wedge" consolidation pattern just below its major long-term resistance.
> Current Status: Closing the week near ₹1,528.90 , the stock has confirmed that buyers are aggressively defending the newly established floor (₹1,450 - ₹1,480).
📊 2. Volume & Indicators
> Moving Averages: The stock is trading comfortably above all key moving averages (10, 20, 50, and 200-Week SMAs/EMAs), confirming absolute trend harmony.
> RSI: The Weekly RSI is hovering in the 60–65 range. This is the ideal "Markup" zone—strong enough to indicate bullish momentum, but far from being overextended or overbought (>70).
🎯 3. Future Scenarios & Key Levels
The stock is absorbing final resistance before challenging its peak.
🐂 Bullish Targets (The Extension):
- Target 1: ₹1,615. .
- Target 2: ₹1,750+. .
🛡️ Support (The "Must Hold"):
- Immediate Support: ₹1,450 – ₹1,480. This breakout zone is the line in the sand. The Polarity Principle dictates this old ceiling must now act as the floor.
- Stop Loss: A weekly close below ₹1,380 would invalidate the bullish breakout structure and trap late buyers.
IPCA Labs – Trend Reversal After Long ConsolidationNSE:IPCALAB has successfully transitioned from a downtrend into a bullish structure after months of sideways consolidation. The breakout above the falling trendline followed by a controlled pullback suggests accumulation.
As long as price holds above ₹1450, the trend remains positive and a fresh breakout above ₹1500 can open the door for further upside.
IPCA Labs | Base Formation with EMA Support – Breakout WatchNSE:IPCALAB Price is trading above the 20/50/100 EMAs, indicating improving short-term momentum after a prolonged consolidation. Volume expansion suggests accumulation, while RSI remains above 50 without being overbought, leaving room for upside. A sustained move above the range resistance could trigger a fast momentum move, while the EMA zone acts as immediate support.
IPCALAB: Technical Breakout AnalysisAfter nearly four years of horizontal consolidation, IPCALAB has executed a textbook Weinstein Stage 1 to Stage 2 breakout. The stock has spent months absorbing multi-year overhead supply, and this week’s decisive price action marks a significant Change of Character (CoC) from a neutral basing phase to an active uptrend.
Technical Analysis & Breakout Factors
Pattern Recognition: The stock has successfully emerged from a year-long Pennant Consolidation that formed right at its major 4-year resistance level of ₹1,380. This "squeeze" at the range high is a classic sign of institutional absorption.
Trend Alignment: Price is trading above ALL key moving averages (10, 20, 50, 200-Day SMA). Notably, the 50-DMA has recently crossed above the 200-DMA (Golden Cross), confirming long-term trend reversal and new-found momentum.
Relative Strength (RS): RS has turned GREEN. IPCALAB has gained 11% in the last week, significantly outperforming both the Nifty 50 and the Nifty Pharma Index. This divergence indicates the stock is a new sector leader.
Volume Confirmation: The breakout is supported by decent volume expansion. Current volume is approximately 3x the 20-day average, validating the conviction behind the move.
Supply Absorption: While there is minor historical supply near ₹1,600–₹1,650, the strength of the breakout candle and the clear "Cup and Handle" retest suggest that current demand is sufficient to clear these overhead hurdles.
📝 Key Takeaway for Traders
IPCALAB is a classic "Big Base" breakout. The confluence of a 1-year breakout, positive Relative Strength, and accelerating earnings (23% YoY profit growth) makes this one of the strongest setups in the Pharma sector currently. Trade the trend, respect the Stop-Loss.
Disclaimer: This is a technical analysis template for educational purposes only and does not constitute financial advice. Always perform your own research.
Double Bottom + Falling Wedge = Breakout Loading on IPCALABChart Overview
Pattern: Falling Wedge inside a confirmed bullish structure
Structure Break: BOS (Break of Structure) already confirmed
Key Levels:
Order Block Zone: Around ₹1300–₹1310
Current Price: ₹1325
Target Zone: ₹1430
Stop-Loss: Below ₹1300
Technical Breakdown
1. Double Bottom
The formation of Bottom1 and Bottom2 shows a strong demand base.
The BOS (Break of Structure) after Bottom2 confirms that buyers took control.
2. Falling Wedge Pattern
After the BOS, the price is consolidating in a Falling Wedge, which is typically a bullish continuation pattern.
Price respecting the wedge boundaries suggests compression — a breakout to the upside can trigger momentum.
3. Order Block Zone
The blue rectangular area marks a bullish order block from the last strong bullish rally.
Price has retraced back into this OB, creating an ideal entry point if bullish rejection appears.
4. Trade Setup
Entry: Near ₹1320–₹1325
Stop-Loss: Below ₹1300 (OB invalidation)
Target: ₹1430
RR Ratio: ≈ 1:4
IPCALAB 1 Hour View📊 1-Hour Timeframe: Support & Resistance Levels
Based on recent intraday data, here are the key support and resistance levels for IPCA Laboratories Ltd. on the 1-hour timeframe:
🔽 Support Levels:
S1: ₹1,324.36
S2: ₹1,323.13
S3: ₹1,322.06
🔼 Resistance Levels:
R1: ₹1,326.66
R2: ₹1,327.73
R3: ₹1,328.96
These levels are derived from standard pivot point calculations and are widely used by traders to identify potential reversal points.
📈 Technical Indicators Overview
RSI (14): 43.40 — indicates a neutral momentum.
MACD: -7.96 — suggests a bearish trend.
ADX: 39.75 — points to a neutral trend strength.
Moving Averages:
5-period EMA: ₹1,325.64 — indicates a buy signal.
50-period EMA: ₹1,352.22 — suggests a sell signal.
200-period EMA: ₹1,351.26 — indicates a sell signal.
Pivot Points:
Pivot: ₹1,325.43
R1: ₹1,326.66
S1: ₹1,324.36
These indicators collectively suggest a cautious outlook for short-term traders, with a prevailing bearish sentiment.
#IPCALAB - Rounding Bottom Breakout in DTF/ Keep in WL📊 Script: IPCALAB
Key highlights: 💡⚡
📈 Rounding Bottom Formation in Daily Time Frame
📈 Price consolidating near Resistance, then Breakout
📈 Volume spike during Breakout
📈 MACD Bounce
📈 Can go for a swing trade
BUY ONLY ABOVE 1535 DCB
⏱️ C.M.P 📑💰- 1514
🟢 Target 🎯🏆 – 12%
⚠️ Stoploss ☠️🚫 – 6%
⚠️ Important: Market conditions are Okish, Position size 50% per Trade. Protect Capital Always
⚠️ Important: Always Exit the trade before any Event.
⚠️ Important: Always maintain your Risk:Reward Ratio as 1:2, with this RR, you only need a 33% win rate to Breakeven.
✅Like and follow to never miss a new idea!✅
Disclaimer: I am not SEBI Registered Advisor. My posts are purely for training and educational purposes.
Eat🍜 Sleep😴 TradingView📈 Repeat 🔁
Happy learning with MMT. Cheers!🥂
IPCA LABORATORIES - RETEST OF SUPPORT BREAKDOWNSymbol - IPCALAB
Ipca Laboratories has recently experienced notable price movements, trading near resistance levels after a good pullback from lower levels. Currently, the stock is trading near major resistance zone, which follows a period of strong recovery from its earlier lows. However, the trend appears bearish, and the sentiment is negative. This increases the likelihood of a sell-off from the ₹1500-₹1540 resistance zone, where the stock may face significant selling pressure.
Despite the recent price recovery, the stock is encountering selling pressure near these resistance levels, reflecting a similar trend seen in many healthcare stocks due to changing investor sentiments. As with other pharmaceutical companies, the stock could face volatility due to external factors such as regulatory updates, changes in pricing strategies, or new competition in the market.
Despite short-term fluctuations, the stock remains resilient due to strong fundamentals and an ongoing focus on key therapeutic segments. However, the short-term outlook might face a correction. This could trigger a move towards lower levels, but long-term growth remains intact based on strong earnings prospects and solid market positioning.
Key Resistance levels: ₹1500, ₹1540, ₹1548
Key Support levels: ₹1460, ₹1434, ₹1400
There are no signs of a significant trend reversal, and growth could resume from lower levels should the stock maintain its strong performance fundamentals.
Disclaimer - Do not consider this as a buy/sell recommendation. I'm sharing my analysis & my trading position. You can track it for educational purposes. Thanks!
The trend is strongIPCA CMP 1470
Elliott- thats an expanded flat corrective pattern on the right. The C wave is 1.618 of A. Hence to me the correction is over.
Fibs- the correction has halted at 50% from a higher swing. This is strength.
RSI- the oscillator has halted above the bull zone. Hence the trend is intact.
Conclusion - to me this is still a very good buy as the trend is intact and strong. The Pharma sector is yet another sector that should outperform the Nifty.
PCA Laboratories LtdThe chart for IPCA Laboratories Ltd. (NSE) displays a potential flag pattern breakout, suggesting bullish momentum continuation. The price has broken out above the consolidation range, supported by a prior strong rally (flagpole) and notable volume activity. The RSI is near 62, indicating bullish momentum while leaving room for further upside before reaching overbought levels. The MACD shows a bullish crossover, with the MACD line above the signal line and a growing positive histogram, reinforcing the bullish outlook.
Key support levels are observed at ₹1,550 (lower trendline of the flag), ₹1,400, and ₹1,200, providing strong downside protection. Resistance levels to monitor include ₹1,700 (immediate), ₹1,850, and ₹2,000 (long-term target). Traders can consider entering around ₹1,650, ensuring the breakout sustains, with a stop-loss at ₹1,550 to manage risk. The targets for this trade are ₹1,700 (short-term), ₹1,850, and ₹2,000 (long-term, based on the flagpole projection).
While the breakout setup appears favorable, traders should remain cautious, especially if the price approaches overbought RSI levels, as a short-term consolidation or pullback could occur. A sustained close above ₹1,700 with strong volume will confirm the continuation of bullish momentum toward higher targets.
IPCA Lab Short IntradayIPCA is weak with volume. On critical price junction. We will wait for breakout for intraday shorts.
Trade Signal is 1503.4. Stock has taken support at this exact level multiple time.
Once break 1500 stock is weak and short trade get confirmation. We can keep target 1585-80
Once stock goes to 1590 we move our SL to 1501.
All levels are mentioned in stock.
IPCA LABS - Shorts below 1550 you may think of buying a put option or selling futures if IPCA labs closes below 1550 levels and then you can thank me later by boosting, liking and sharing the post.
One of the first modern pharma factory of yesteryears was commissioned by Ipca at Mumbai in 1969. The company was originally promoted by a group of medical professionals and businessmen and was incorporated as 'The Indian Pharmaceutical Combine Association Limited. ' in October 1949.
Thank you.
IPCALAB 1HRSWING TRADE
- EARN WITH ME DAILY 10K-20K –
IPCALAB Looking good for Downside..
When it break level 1558 and sustain.. it will go Downside...
SELL @ 1558
Target
1st 1548
2nd 1535
FNO
IPCALAB NOV FUT – LOT 6 (Qty-3900)
IPCALAB NOV 6200 PE – LOT 6 (Qty-3900) – PRICE (70.40)
Enjoy trading traders.. Keep add this STOCK in your watch list..
Big Investor are welcome..
Like this Post??? Hit like button..!!!
Follow me for FREE Educational Post and Alert..
IPCALAPEntry @1655 Above Close or retest range
Hold 1 month
Target 10% and 20%
SL day candle close only, Target Trigger Price
All detail for chat. good entry at mark price only. and must stoploss minimum risk and good profit. risk ratio 1:1 to manage modified SL. This is not call, Just my idea. Please understand your risk and take full responsibility of your actions
IPCA Lab - Observing Buy SetupCMP 1361 on 09.08.24
The above weekly chart shows that the price has formed a cup & handle pattern in the last 2 years. If this pattern continues we can expect a breakout on the charts.
MACD is showing a likely crossover too.
Possible targets may be 1600/1800 or even more.
As long as it sustains above 1300, this setup remains relevant.
Decide your exit levels according to your position sizing and risk-management.
This illustration is only for learning and sharing purposes, not a piece of trading advice in any form.
All the best.
IPCALAB: Multi-Year Breakout: Monthly Timeframe: Oct'24IPCALAB: Multi-Year Breakout: Monthly Timeframe: Oct'24
Stock comfortably broke the high (1383.1) it made in Sep'21 and closed above in Sep'24. A multi-year breakout on a monthly time frame
RSI in Sep'24 (63.27) is above 60.
Breakout in Sep did not happen with above average trade volume (9 SMA)
Drawdown = 713.3/-
Target = Breakout level + Drawdown during consolidation phase = 1383.1 + 713.3 ~ 2090
ATR = 136.47
SuperTrend = 1020.92
Stop Loss = 1 ATR below previous month's low = 1375 - 136.47 ~ 1235






















